|
Below is an in-depth analysis and side-by-side comparison of Vital Dent vs Baxter International including start-up costs and fees, business experience requirements, training & support and financing options.
Start-Up Costs and Fees |
||
Investment | $512,500 - $797,000 | $54,450 - $67,450 |
Franchise Fee | $45,000 - $60,000 | $20,000 |
Royalty Fee | 5% | 5% |
Advertising Fee | - | - |
Year Founded | 1989 | - |
Year Franchised | 1995 | - |
Term Of Agreement | 10years | - |
Term Of Agreement | 10years | - |
Renewal Fee | $3000/ treatment room | - |
Business Experience Requirements |
||
Experience | - | - |
Financing Options |
||
In-House/3rd Party | In-House/3rd Party | |
Franchise Fees | No/No | -/- |
Start-up Costs | No/No | -/- |
Equipment | No/No | -/- |
Inventory | No/No | -/- |
Receivables | No/No | -/- |
Payroll | No/No | -/- |
Training & Support |
||
Training | - | - |
Support | - | - |
Marketing | - | - |
Operations | - | - |
Expansion Plans |
||
US Expansion | - | - |
Canada Expansion | No | - |
International Expansion | No | - |
Vital Dent, a well-respected leader in the dental health care field, is a multi-national company which began business in Spain in 1989. Started first as a dental prosthetics business, in 1991 the company began developing dental offices. Then in 1995, Vital Dent established its franchise system.
Vital Dent owns and operates 23 company offices and 160 franchised offices in Spain, with another 10 franchised offices in Portugal and 2 offices being built in Italy.
The Vital Dent franchise network is now being developed in the United States.
Baxter gives an expansive arrangement of fundamental renal and clinic items, including home, intense and in-focus dialysis; clean IV arrangements; implantation frameworks and gadgets; parenteral sustenance; biosurgery items and sedatives; and drug store mechanization, programming and administrations. The organization's worldwide impression and the basic way of its items and administrations assume a key part in growing access to medicinal services in rising and created nations. Baxter's representatives worldwide are expanding upon the organization's rich legacy of therapeutic leaps forward to propel the up and coming era of social insurance developments that empower tolerant care.